Skip to main content
Clinical Trials/NCT03910400
NCT03910400
Unknown
Not Applicable

EARLY Microvascular Dysfunction Assessment Using Quantitative Flow Ratio After ST-segment Elevation MYOcardial Infarction (EARLY-MYO-QFR II)

RenJi Hospital1 site in 1 country200 target enrollmentFebruary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ST Segment Elevation Myocardial Infarction
Sponsor
RenJi Hospital
Enrollment
200
Locations
1
Primary Endpoint
Cardiac magnetic resonance (CMR)
Last Updated
6 years ago

Overview

Brief Summary

The study intends to provide new data on whether the noval method using quantitative flow ratio could assess microvascular dysfunction based on the previous study EARLY-MYO-QFR-I.

Detailed Description

Microvascular dysfunction (MVD) is a serious complication of PCI, which happens frequently after STEMI and always correlates with a poor prognosis. However, precise and simplified assessment of MVD is difficult, especially in the acute phase of STEMI patients. Resent studies suggested that FFR could be overestimated when MVD exists. But whether the overestimated value of FFR caused by CMR defined microvascular obstruction (MVO) could reflect microvascular function is still unclear. In the previous study EARLY-MYO-QFR-I, we have demonstrated that the relationship between Contrast-enhanced CMR defined MVO and QFR. While angiography images were collected on a retrospectively manner, and the study population were selected (STEMI patients with spontaneously recanalized culprit vessel before PCI) to verify our hypothesis. This phase of study would be a prospective study. We tend to created a new study population by a temporary artificial stenosis inside the stent by partially inflating a balloon catheter during pharmacologic hyperemia in STEMI patients.

Registry
clinicaltrials.gov
Start Date
February 1, 2019
End Date
March 1, 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • STEMI patients treated with revasculation within 12 hours from onset of symptoms to PCI time and received CMR 5 days afterwards. STEMI was defined as a combination of the following: chest pain for more than 30min, electrocardiographic (ECG) changing with ST segment elevation of \>2 mm in at least 2 precordial leads and \>1 mm in limb leads, and abnormal troponin levels or CKMB levels higher than twice the upper limit of normal.
  • Stents were implanted whenever technically possible.
  • TFG 2/3 after PCI.

Exclusion Criteria

  • Patients with left bundle branch block in the presenting ECG, cardiogenic shock, previous PCI or bypass surgery, previous AMI history.
  • Patients with trouble in partially inflating a balloon catheter during pharmacologic hyperemia.
  • Patients with unqualified coronary angiographic images with problems such as ostial lesion, severe vessel tortuosity and diffuse long lesions.

Outcomes

Primary Outcomes

Cardiac magnetic resonance (CMR)

Time Frame: Five days after PCI

Cardiac magnetic resonance (CMR) is a non-invasive test for MVO assessing

Secondary Outcomes

  • TIMI Flow Grade (TFG)(One minutes after PCI)
  • TIMI Myocardial Perfusion Grade (TMPG)(One minutes after PCI)
  • ST-segment resolution (STR)(90 minutes after PCI)

Study Sites (1)

Loading locations...

Similar Trials